Other
European Hepatocellular Cancer Liver Transplant Group
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
No phase data available
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT06799468Completed
Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation
Role: lead
NCT05200195Completed
Deep Learning Model for the Prediction of Post-LT HCC Recurrence
Role: lead
NCT03723304Completed
The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients
Role: lead
NCT03595345Completed
A Worldwide Score for Hepatocellular Cancer and Liver Transplantation
Role: lead
NCT03723317Completed
Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival
Role: lead
All 5 trials loaded